Subscribe

Get latest conversations to your inbox

If you're enjoying this conversation, please subscribe to stay tuned for upcoming conversations.

Tim Ko and John Lem (HaluGen): Genetic Testing for the Psychedelics Experience

October 22, 2021

What if a simple test could reveal the speed of your psychedelic metabolism or your propensity for psychedelic-triggered mental health issues?

Providing information on 5 key genetic variants, HaluGen Life Sciences is a direct to consumer test and an educational tool to help us all understand the various factors that impact the psychedelic experience.

On today’s show I speak with Tim Ko and John Lem from Entheon, the company behind HaluGen. On the show, we review each of the biomarkers they test for including three biomarkers for general mental health risks, a variant that causes slower Ketamine metabolization, and a variant that increases the density of serotonin 2A receptors. We discuss the potential actionability of this data and how Entheon sees the tool developing over time.

Timothy Ko has a broad background of leading private ventures in the Service Sector, Investor Relations, Retail and Technology. Timothy’s passion for the psychedelic space is shaped by firsthand knowledge of the shortcomings of the current mental health system, and through his exposure to psychedelics which he credits with saving his life. John Lem is the co-founder of Spartan Bioscience and Lobo Genetics with 15 years experience in life sciences, medical devices and capital markets.

Show notes

Links

Timestamps

  • :04 - Tim Ko’s personal history and passion for psychedelic healing
  • :15 - What is Entheon?
  • :21 - Population breakdowns for genetic mutations
  • :26 - Three biomarkers for general mental health risks
  • :41 - A genetic variant which causes people to metabolize ketamine more slowly
  • :45 - A variant that increases the density and serotonin 2A receptors
  • :54 - Future biomarkers to study
  • :59 - What will HaluGen 2.0 look like
LinkedIn pink iconInstagram pink iconFacebook pink iconTwiter pink iconYoutube pink icon

About Maya’s Podcast

A conversation series with leaders in the psychedelic community. Designed in service of therapists, healers, retreat leaders, and passionate enthusiasts

View all episodes

Other podcasts you may also like

August 18, 2022

Alexandre Tannous: Psychedelics & Sound Meditation

Can sound help us disconnect from unhealthy habitual patterns? Today’s guest Alexandre Tannous, creator of the Sound Meditation protocol, shows how we can use harmonic frequencies to release trauma, enhance self-awareness and live happier lives.

Listen to Podcast
June 10, 2022

Talia Eisenberg (Beond): How Ibogaine Gets to the Root of Trauma

The West African psychedelic iboga (and its extraction ibogaine) continues to show an impressive ability to heal addiction and trauma.

Listen to Podcast
May 5, 2022

Adele Lafrance: Healing Eating Disorders with Psychedelics

The promising impact that ayahuasca, MDMA, ketamine, and psilocybin can have on a person who is struggling to heal from disordered eating.

Listen to Podcast